FDA Approves Ropeginterferon Alfa-2b in Essential Thrombocythemia
FDA Approves Ropeginterferon Alfa-2b in Essential Thrombocythemia The American Journal of Managed Care
Regulatory Approvals
FDA Approves First Essential Thrombocythemia Drug in Nearly 30 Years
FDA Approves First Essential Thrombocythemia Drug in Nearly 30 Years Oncology News Central
Ultragenyx Pharmaceutical (RARE) Wins FDA Approval, Is The Stock Fully Priced?
Ultragenyx Pharmaceutical (RARE) Wins FDA Approval, Is The Stock Fully Priced? Yahoo Finance
MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance
MiniMed wins CE mark for next-gen insulin pump, ups revenue guidance Drug Delivery Business
Business Watch: Solstice, Element cancel deal; FDA approves daraxonrasib for pancreatic cancer
Business Watch: Solstice, Element cancel deal; FDA approves daraxonrasib for pancreatic cancer C&EN